Differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma

Differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma

To investigate the differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization (DEB-BACE) combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma. Totally 60 cases of unresectable lung squamous cell carcinoma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Zhong hua yi xue za zhi 2020-04, Vol.100 (15), p.1164
Hauptverfasser: Huang, R, Li, W H, Zhu, J, Li, C L, Wan, H G, Chen, L Z
Format: Artikel
Sprache:chi
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 15
container_start_page 1164
container_title Zhong hua yi xue za zhi
container_volume 100
creator Huang, R
Li, W H
Zhu, J
Li, C L
Wan, H G
Chen, L Z
description To investigate the differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization (DEB-BACE) combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma. Totally 60 cases of unresectable lung squamous cell carcinoma undergoing systemic chemotherapy in Yancheng Third People Hospital were retrospectively selected as the research object. According to patients' wishes, they were divided into chemotherapy-only group (group A) and combined treatment group (group B). Group A received gemcitabine combined with cisplatin chemotherapy. DEB-BACE was applied in the first half, and systemic chemotherapy was administered in the second half (starting 3 d after BACE). The first half and the second half of the chemotherapy dose were 1/2 of the drug dose in the chemotherapy alone group. The short-term efficacy, incidence of toxic side effects, peripheral blood T lymphocyte subsets, serum vascular endothelial growth factor (VEGF) levels, and sur
doi_str_mv 10.3760/cma.j.cn112137-20190816-01824
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_32311881</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32311881</sourcerecordid><originalsourceid>FETCH-LOGICAL-p561-62b6ebaafc2fa5e06c3c8338a0a7a54b84f07e60db3bb1ff4db7ec86ce4304983</originalsourceid><addsrcrecordid>eNp1ULtOAzEQdAEiCPgF5Ibygh-XO6dEvCUkmvRovbdOjM52sH1C4SP5JoKAkmpGO6OZ1TB2IcVc9524xADz1zlGKZXUfaOEXAoju0ZIo9oDdiz2rka1SzljZ6V4K9peL5VQ8ojNtNJSGiOP2eeNd44yRaTCfeTknEfAHbdU34kiH_K0bmicqo_r_RGGwmuGWGxOETceRg65Uv4muKGQKNg0-g-oPkWOKVgfaeDvvm542ZVKweOPsW4ow3bHIQ7_KWOKxF3KfIqZCmEFOxIfp_0n5W2CkKbCkcZ9M2T0MQU4ZYcOxkJnv3jCVne3q-uH5un5_vH66qnZLjrZdMp2ZAEcKgcLEh1qNFobENDDorWmdaKnTgxWWyudawfbE5oOqdWiXRp9ws5_YreTDTS8bLMPkHcvf7vqL7ltheI</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Huang, R ; Li, W H ; Zhu, J ; Li, C L ; Wan, H G ; Chen, L Z</creator><creatorcontrib>Huang, R ; Li, W H ; Zhu, J ; Li, C L ; Wan, H G ; Chen, L Z</creatorcontrib><description>To investigate the differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization (DEB-BACE) combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma. Totally 60 cases of unresectable lung squamous cell carcinoma undergoing systemic chemotherapy in Yancheng Third People Hospital were retrospectively selected as the research object. According to patients' wishes, they were divided into chemotherapy-only group (group A) and combined treatment group (group B). Group A received gemcitabine combined with cisplatin chemotherapy. DEB-BACE was applied in the first half, and systemic chemotherapy was administered in the second half (starting 3 d after BACE). The first half and the second half of the chemotherapy dose were 1/2 of the drug dose in the chemotherapy alone group. The short-term efficacy, incidence of toxic side effects, peripheral blood T lymphocyte subsets, serum vascular endothelial growth factor (VEGF) levels, and sur</description><identifier>ISSN: 0376-2491</identifier><identifier>DOI: 10.3760/cma.j.cn112137-20190816-01824</identifier><identifier>PMID: 32311881</identifier><language>chi</language><publisher>China</publisher><ispartof>Zhong hua yi xue za zhi, 2020-04, Vol.100 (15), p.1164</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32311881$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huang, R</creatorcontrib><creatorcontrib>Li, W H</creatorcontrib><creatorcontrib>Zhu, J</creatorcontrib><creatorcontrib>Li, C L</creatorcontrib><creatorcontrib>Wan, H G</creatorcontrib><creatorcontrib>Chen, L Z</creatorcontrib><title>Differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma</title><title>Zhong hua yi xue za zhi</title><addtitle>Zhonghua Yi Xue Za Zhi</addtitle><description>To investigate the differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization (DEB-BACE) combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma. Totally 60 cases of unresectable lung squamous cell carcinoma undergoing systemic chemotherapy in Yancheng Third People Hospital were retrospectively selected as the research object. According to patients' wishes, they were divided into chemotherapy-only group (group A) and combined treatment group (group B). Group A received gemcitabine combined with cisplatin chemotherapy. DEB-BACE was applied in the first half, and systemic chemotherapy was administered in the second half (starting 3 d after BACE). The first half and the second half of the chemotherapy dose were 1/2 of the drug dose in the chemotherapy alone group. The short-term efficacy, incidence of toxic side effects, peripheral blood T lymphocyte subsets, serum vascular endothelial growth factor (VEGF) levels, and sur</description><issn>0376-2491</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1ULtOAzEQdAEiCPgF5Ibygh-XO6dEvCUkmvRovbdOjM52sH1C4SP5JoKAkmpGO6OZ1TB2IcVc9524xADz1zlGKZXUfaOEXAoju0ZIo9oDdiz2rka1SzljZ6V4K9peL5VQ8ojNtNJSGiOP2eeNd44yRaTCfeTknEfAHbdU34kiH_K0bmicqo_r_RGGwmuGWGxOETceRg65Uv4muKGQKNg0-g-oPkWOKVgfaeDvvm542ZVKweOPsW4ow3bHIQ7_KWOKxF3KfIqZCmEFOxIfp_0n5W2CkKbCkcZ9M2T0MQU4ZYcOxkJnv3jCVne3q-uH5un5_vH66qnZLjrZdMp2ZAEcKgcLEh1qNFobENDDorWmdaKnTgxWWyudawfbE5oOqdWiXRp9ws5_YreTDTS8bLMPkHcvf7vqL7ltheI</recordid><startdate>20200421</startdate><enddate>20200421</enddate><creator>Huang, R</creator><creator>Li, W H</creator><creator>Zhu, J</creator><creator>Li, C L</creator><creator>Wan, H G</creator><creator>Chen, L Z</creator><scope>NPM</scope></search><sort><creationdate>20200421</creationdate><title>Differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma</title><author>Huang, R ; Li, W H ; Zhu, J ; Li, C L ; Wan, H G ; Chen, L Z</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p561-62b6ebaafc2fa5e06c3c8338a0a7a54b84f07e60db3bb1ff4db7ec86ce4304983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>chi</language><creationdate>2020</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Huang, R</creatorcontrib><creatorcontrib>Li, W H</creatorcontrib><creatorcontrib>Zhu, J</creatorcontrib><creatorcontrib>Li, C L</creatorcontrib><creatorcontrib>Wan, H G</creatorcontrib><creatorcontrib>Chen, L Z</creatorcontrib><collection>PubMed</collection><jtitle>Zhong hua yi xue za zhi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, R</au><au>Li, W H</au><au>Zhu, J</au><au>Li, C L</au><au>Wan, H G</au><au>Chen, L Z</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma</atitle><jtitle>Zhong hua yi xue za zhi</jtitle><addtitle>Zhonghua Yi Xue Za Zhi</addtitle><date>2020-04-21</date><risdate>2020</risdate><volume>100</volume><issue>15</issue><spage>1164</spage><pages>1164-</pages><issn>0376-2491</issn><abstract>To investigate the differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization (DEB-BACE) combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma. Totally 60 cases of unresectable lung squamous cell carcinoma undergoing systemic chemotherapy in Yancheng Third People Hospital were retrospectively selected as the research object. According to patients' wishes, they were divided into chemotherapy-only group (group A) and combined treatment group (group B). Group A received gemcitabine combined with cisplatin chemotherapy. DEB-BACE was applied in the first half, and systemic chemotherapy was administered in the second half (starting 3 d after BACE). The first half and the second half of the chemotherapy dose were 1/2 of the drug dose in the chemotherapy alone group. The short-term efficacy, incidence of toxic side effects, peripheral blood T lymphocyte subsets, serum vascular endothelial growth factor (VEGF) levels, and sur</abstract><cop>China</cop><pmid>32311881</pmid><doi>10.3760/cma.j.cn112137-20190816-01824</doi></addata></record>
fulltext fulltext
identifier ISSN: 0376-2491
ispartof Zhong hua yi xue za zhi, 2020-04, Vol.100 (15), p.1164
issn 0376-2491
language chi
recordid cdi_pubmed_primary_32311881
source EZB-FREE-00999 freely available EZB journals
title Differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T15%3A59%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differences%20in%20efficacy%20between%20drug-eluting%20beads%20transbronchial%20arterial%20chemoembolization%20combined%20with%20systemic%20chemotherapy%20and%20systemic%20chemotherapy%20alone%20for%20unresectable%20lung%20squamous%20cell%20carcinoma&rft.jtitle=Zhong%20hua%20yi%20xue%20za%20zhi&rft.au=Huang,%20R&rft.date=2020-04-21&rft.volume=100&rft.issue=15&rft.spage=1164&rft.pages=1164-&rft.issn=0376-2491&rft_id=info:doi/10.3760/cma.j.cn112137-20190816-01824&rft_dat=%3Cpubmed%3E32311881%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32311881&rfr_iscdi=true